Johns Hopkins investigators study experimental dengue vaccine; Nabi scores $8M;

Vaccine Research

Investigators at Johns Hopkins have begun a human study of a new dengue vaccine that's been in development at the NIAID for more than 10 years. Report

Nabi Biopharmaceuticals has scored an $8 million milestone after a successful technology transfer of program know-how associated with the sale of the PentaStaph vaccine candidate. Nabi release

Cancer vaccine developer MabVax Therapeutics has received a follow-on Phase II grant award from the National Cancer Institute under the Small Business Technology Transfer Program. MabVax release

In a new study of four adenovirus vectors, researchers from The Wistar Institute show that a reportedly rare human adenovirus, called AdHu26, is not so rare, and would thus be unlikely to be optimal as a vaccine carrier for mass vaccination. Wistar release

A research team from Berlin's Max Planck Institute for Infection Biology says it's successfully tested a new, antibiotic-based vaccine for malaria in mice and plan to launch a human trial soon. Story

Vaccine Market

Dendreon has had its hand slapped by the FDA, which cited the company for using promotional material that exaggerated the benefits and underplayed the dangers of its new Provenge prostate cancer vaccine. Report

For the first time in three years, Merck says that its full line of pediatric vaccines is available. The pharma giant has had to grapple with a number of manufacturing problems since 2007. Report

After witnessing the side effects linked to one of CSL's flu vaccines for children, U.S. officials are recommending that doctors find an alternative. Story